R. Le Nué
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
R. Le Nué has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
B. Escande
1 shared publicationC. Bouteiller
1 shared publicationC. Gomes-Ferreira
1 shared publicationC. Scheib-Brolly
1 shared publicationD. Goossens
1 shared publicationE. Dobremez
1 shared publication
Latest Publications
- 1 October 2012
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 8 (5) , 497-503
Evolution of the management of acquired neurogenic bladder in children using intradetrusor botulinum toxin type A injections: 5-year experience and perspectives
- 1 October 2012
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 8 (5) , 497-503
Evolution of the management of acquired neurogenic bladder in children using intradetrusor botulinum toxin type A injections: 5-year experience and perspectives
- 24 June 2010
- Published by Georg Thieme Verlag KG in European Journal of Pediatric Surgery
- Vol. 20 (05) , 307-311
Surgical Management of Congenital Chylothorax in Children
Purpose: Aim of the study was to determine the role of surgery in the management of congenital chylothorax (CC). Methods: We retrospectively reviewed the data of patients with CC requiring medical or surgical treatment postnatally in our institution between January 2001 and March 2009. Results: Ten patients were treated for CC. We divided our population into 2 groups: group A consisted of patients in whom CC healed after conservative medical treatment (thoracocentesis, pleural drainage, total parental nutrition, somatostatin, intrapleural injections of povidone-iodine), and group B of patients who needed both medical and surgical treatment (pleural abrasion and/or pleurectomy). Conservative postnatal therapy was successful in 50% of cases. Of the 3 patients treated preoperatively with intrapleural injections of povidone-iodine, 2 presented with severe complications. Surgical treatment was successful in all cases, with no surgical complications. Patients in group B had a significantly lower birth term (p=0.0254) and birth weight (p=0.0021) compared to patients in group A. Patients with a massive chylothorax (≥50 mL/kg/day) needed surgery significantly more often than those with chylothorax 50 mL/kg/day. Long-term follow-up is needed to evaluate the potential consequences of this therapy.
- 24 June 2010
- Published by Georg Thieme Verlag KG in European Journal of Pediatric Surgery
- Vol. 20 (05) , 307-311
Surgical Management of Congenital Chylothorax in Children
Purpose: Aim of the study was to determine the role of surgery in the management of congenital chylothorax (CC). Methods: We retrospectively reviewed the data of patients with CC requiring medical or surgical treatment postnatally in our institution between January 2001 and March 2009. Results: Ten patients were treated for CC. We divided our population into 2 groups: group A consisted of patients in whom CC healed after conservative medical treatment (thoracocentesis, pleural drainage, total parental nutrition, somatostatin, intrapleural injections of povidone-iodine), and group B of patients who needed both medical and surgical treatment (pleural abrasion and/or pleurectomy). Conservative postnatal therapy was successful in 50% of cases. Of the 3 patients treated preoperatively with intrapleural injections of povidone-iodine, 2 presented with severe complications. Surgical treatment was successful in all cases, with no surgical complications. Patients in group B had a significantly lower birth term (p=0.0254) and birth weight (p=0.0021) compared to patients in group A. Patients with a massive chylothorax (≥50 mL/kg/day) needed surgery significantly more often than those with chylothorax 50 mL/kg/day. Long-term follow-up is needed to evaluate the potential consequences of this therapy.